ATNM · Categories · Form 4

ATNM - SEC Form 4 insider transactions

Actinium Pharmaceuticals Inc. (Delaware) (ATNM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ATNM

• 293d
  Chief Executive Officer Seth Sandesh covered exercise/tax liability with 120,900 shares, decreasing direct ownership by 40% to 184,481 units (SEC Form 4)

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Director Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Director Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Director Almenoff June Sherie

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Director Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Director Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Chief Executive Officer Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 433d
  SEC Form 4 filed by Chief Financial Officer O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 581d
  SEC Form 4 filed by Director Almenoff June Sherie

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 893d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1390d
  SEC Form 4: Seth Sandesh was granted 300,000 shares, increasing direct ownership by 5,575% to 305,381 units

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1439d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Berger Mark Stanley

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1740d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)

Other ATNM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends